Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$580M |
| 2 |
Broadcom
AVGO
|
+$511M |
| 3 |
Tesla
TSLA
|
+$471M |
| 4 |
American International
AIG
|
+$438M |
| 5 |
Advanced Micro Devices
AMD
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$444M |
| 2 |
Synopsys
SNPS
|
+$348M |
| 3 |
Pinduoduo
PDD
|
+$326M |
| 4 |
NetEase
NTES
|
+$314M |
| 5 |
DexCom
DXCM
|
+$302M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.37% |
| 2 | Financials | 12.15% |
| 3 | Industrials | 11.37% |
| 4 | Healthcare | 11.18% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
UroGen Pharma
URGN
$1.88B
| $152K | ﹤0.01% |
10,102
+47
| +0.5% | +$610 |
|
3502
Evolus
EOLS
$379M
| $151K | ﹤0.01% |
14,363
-2,624
| -15% | -$23.5K |
|
3503
Biomea Fusion
BMEA
$86M
| $149K | ﹤0.01% |
10,262
-7,762
| -43% | -$94.3K |
|
|
CDMO
3504
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $149K | ﹤0.01% |
22,913
-205,413
| -90% | -$1.32M |
|
3505
Spruce Power Holding Corp
SPRU
$36.2M
| $149K | ﹤0.01% |
33,670
+449
| +1% | +$1.88K |
|
3506
Xeris Biopharma Holdings
XERS
$1.39B
| $148K | ﹤0.01% |
63,177
-256,471
| -80% | -$473K |
|
|
EVA
3507
DELISTED
Enviva Inc.
EVA
| $148K | ﹤0.01% |
148,524
-114,619
| -44% | -$318K |
|
3508
Urban One Class D
UONEK
$21.9M
| $146K | ﹤0.01% |
+4,137
| New | +$189K |
|
3509
SoundHound AI
SOUN
$2.67B
| $145K | ﹤0.01% |
68,309
-21,381
| -24% | -$42.4K |
|
|
RERE
3510
ATRenew
RERE
$939M
| $144K | ﹤0.01% |
75,219
-8,423
| -10% | -$14.8K |
|
3511
Waldencast
WALD
$226M
| $144K | ﹤0.01% |
+13,155
| New | +$124K |
|
3512
Lindblad Expeditions
LIND
$1.95B
| $144K | ﹤0.01% |
12,759
+2,683
| +27% | +$20.8K |
|
|
DOYU
3513
DouYu International Holdings
DOYU
$139M
| $144K | ﹤0.01% |
15,111
-1,692
| -10% | -$14.6K |
|
|
DMO
3514
Western Asset Mortgage Opportunity Fund
DMO
$118M
| $143K | ﹤0.01% |
12,788
-23,939
| -65% | -$256K |
|
3515
Babcock & Wilcox
BW
$1.4B
| $143K | ﹤0.01% |
97,641
-54,152
| -36% | -$115K |
|
3516
Arbutus Biopharma
ABUS
$845M
| $142K | ﹤0.01% |
56,673
+58
| +0.1% | +$114 |
|
|
TERN
3517
DELISTED
Terns Pharmaceuticals
TERN
| $141K | ﹤0.01% |
21,791
-19,159
| -47% | -$101K |
|
|
CEPU
3518
Central Puerto
CEPU
$2.29B
| $141K | ﹤0.01% |
15,503
-839
| -5% | -$6.03K |
|
3519
Hyliion Holdings
HYLN
$638M
| $141K | ﹤0.01% |
172,694
+14,931
| +9% | +$10.6K |
|
|
3520
Urban One Class A
UONE
$22.9M
| $140K | ﹤0.01% |
+3,479
| New | +$163K |
|
3521
Immersion
IMMR
$249M
| $139K | ﹤0.01% |
19,733
-25,930
| -57% | -$172K |
|
3522
Omeros
OMER
$845M
| $139K | ﹤0.01% |
42,390
-24,155
| -36% | -$51K |
|
3523
Melco Resorts & Entertainment
MLCO
$2.26B
| $139K | ﹤0.01% |
15,619
-2,574
| -14% | -$21K |
|
3524
Westrock Coffee
WEST
$791M
| $138K | ﹤0.01% |
13,533
-1,569
| -10% | -$14K |
|
3525
Harmony Gold Mining
HMY
$9.78B
| $136K | ﹤0.01% |
+22,111
| New | +$116K |
|
Similar funds
Invesco's Q4 2023 Portfolio in Review
As of Q4 2023, Invesco held 3,965 positions worth $420B, up 13% from $371B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Invesco's Q4 2023 filing shows 126 new, 1,970 increased, 1,592 reduced and 143 closed positions. Its largest new stake was Veralto: 4,358,553 shares worth $359M. The largest sale was Pioneer Natural Resource Co., an estimated $444M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q4 2023 buy was Veralto: 4,358,553 shares worth $359M.
- Invesco added most to Texas Instruments in Q4 2023, an estimated $580M increase.
- Invesco's biggest Q4 2023 reduction was Pioneer Natural Resource Co., cutting an estimated $444M.
- Invesco fully exited Activision Blizzard in Q4 2023, selling an estimated $186M.
- Invesco's ten largest holdings make up 15% of its $420B portfolio in Q4 2023.
- Invesco opened 126 new positions and closed 143 in Q4 2023.
- Invesco's portfolio value rose 13% quarter-over-quarter to $420B.
Based on Invesco's 13F filing for Q4 2023, filed 13 Feb 2024.